Low serum Vitamin D: A surrogate marker for advanced colon adenoma?

Journal of Clinical Gastroenterology

Volumn 50, Issue 8, 2016, Pages 644-648

  Ahmad, Imad I ^a   Trikudanathan, Guru ^d   Feinn, Richard ^b   Anderson, Joseph C ^e   Nicholson, Marie ^c   Lowe, Samantha ^c   Levine, Joel B ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b New York   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

25 OH Vitamin D; adenoma; advanced adenomas; colon neoplasm; Vitamin D deficiency

Indexed keywords

BIOCHEMICAL MARKER; VITAMIN D; 25-HYDROXYVITAMIN D; TUMOR MARKER;

ADULT; ADVANCED CANCER; ARTICLE; CANCER RISK; CANCER SCREENING; COLON ADENOMA; COLON CANCER; COLONOSCOPY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; VITAMIN BLOOD LEVEL; ADENOMA; AGED; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; COLON POLYP; COLON TUMOR; COMPLICATION; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; VITAMIN D DEFICIENCY;

ADENOMA; AGED; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COLONIC POLYPS; COLONOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84959088887     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000497     Document Type: Article

References (34)

1. American Cancer Society (ACS) Colorectal Cancer Facts & Figures 2014-2016 Atlanta: American Cancer Society; 2014: 1-10.
2. Kampman E, Giovannucci E, van?t Veer P, et al. Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol. 1994; 139: 16-29.
3. Boutron MC, Faivre J, Marteau P, et al. Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case-control study. Br J Cancer. 1996; 74: 145-151.
4. Platz EA, Hankinson SE, Hollis BW, et al. Plasma 1, 25-dihydroxy- And 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev. 2000; 9: 1059-1065.
5. Levine AJ, Harper JM, Ervin CM, et al. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer. 2001; 39: 35-41.
6. Wu K, Willett WC, Fuchs CS, et al. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst. 2002; 94: 437-446.
7. Sidelnikov E, Bostick RM, Flanders WD, et al. Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients. Cancer Epidemiol Biomarkers Prev. 2010; 19: 1022-1032.
8. Hartman TJ, Albert PS, Snyder K, et al. The association of calcium and vitamin D with risk of colorectal adenomas. J Nutr. 2005; 135: 252-259.
9. Adams SV, Newcomb PA, Burnett-Hartman AN, et al. Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps. Nutr Cancer. 2011; 63: 319-326.
10. Gandini S, Boniol M, Haukka J, et al. Meta-Analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2011; 128: 1414-1424.
11. Yin L, Grandi N, Raum E, et al. Meta-Analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther. 2009; 30: 113-125.
12. Touvier M, Chan DS, Lau R, et al. Meta-Analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011; 20: 1003-1016.
13. Lee JE, Li H, Chan AT, et al. Circulating levels of vitamin D and colon and rectal cancer: the Physicians? Health Study and a meta-Analysis of prospective studies. Cancer Prev Res. 2011; 4: 735-743.
14. Ahearn TU, Shaukat A, Flanders WD, et al. Markers of the APC/beta-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms. Cancer Epidemiol Biomarkers Prev. 2012; 21: 969-979.
15. Larriba MJ, Ordonez-Moran P, Chicote I, et al. Vitamin D receptor deficiency enhances Wnt/beta-catenin signaling and tumor burden in colon cancer. PloS one. 2011; 6: e23524.
16. Martinez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009; 136: 832-841.
17. Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012; 143: 844-857.
18. Sullivan KM, Dean A, Soe MM. OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Rep. 2009; 124: 471-474.
19. Sy AM, Bautista JE. Association between serum vitamin D levels and colonic carcinomatous polyps. J Gastrointest Cancer. 2013; 44: 481-485.
20. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005; 94: 483-492.
21. Looker AC, Johnson CL, Lacher DA, et al. Vitamin D status: United States, 2001-2006. NCHS Data Brief. 2011; 59: 1-8.
22. Stubbins RE, Hakeem A, Nunez NP. Using components of the vitamin D pathway to prevent and treat colon cancer. Nutr Rev. 2012; 70: 721-729.
23. Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ. 2010; 340: b5500.
24. Bolland MJ, Grey A, Gamble GD, et al. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women?s Health Initiative (WHI) limited-Access data set. Am J Clin Nutr. 2011; 94: 1144-1149.
25. Peters U, Hayes RB, Chatterjee N, et al. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2004; 13: 546-552.
26. Huncharek M, Muscat J, Kupelnick B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-Analysis of 26, 335 cases from 60 observational studies. Nutr Cancer. 2009; 61: 47-69.
27. Peters U, Hutter CM, Hsu L, et al. Meta-Analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet. 2012; 131: 217-234.
28. Kawasaki T, Nosho K, Ohnishi M, et al. Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma. BMC cancer. 2008; 8: 1-8.
29. Wang Q, He Y, Shen Y, et al. Vitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4. J Biol Chem. 2014; 289: 11681-11694.
30. Jacobs ET, Hibler EA, Lance P, et al. Association between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis. Int J Cancer. 2013; 133: 2980-2988.
31. Ashktorab H, Nguza B, Fatemi M, et al. Case-control study of vitamin D, dickkopf homolog 1 (DKK1) gene methylation, VDR gene polymorphism and the risk of colon adenoma in African Americans. PloS one. 2011; 6: e25314.
32. Grau MV, Baron JA, Sandler RS, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003; 95: 1765-1771.
33. Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology. 2010; 138: 2029.e10-2043.e10.
34. Giovannucci E. Epidemiology of vitamin D and colorectal cancer: casual or causal link?. J Steroid Biochem Mol Biol. 2010; 121: 349-354.